Serum cytokine concentrations were not associated with colorectal adenoma recurrence with the exception that a decrease in IL-2 concentrations during the trial increased the risk of any adenoma recurrence, and a decrease in IL-1β or IL-10 reduced the risk of advanced adenoma recurrence. Here, IL1B is linked to adenoma.